Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
7,306
JPY
|
+2.21%
|
|
+2.70%
|
+7.47%
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,130,768
|
1,615,227
|
1,794,318
|
2,270,169
|
1,759,071
|
2,071,189
|
-
|
-
|
Enterprise Value (EV)
1 |
1,804,875
|
1,414,518
|
1,526,132
|
2,022,423
|
1,459,258
|
1,597,836
|
1,505,396
|
1,420,507
|
P/E ratio
|
16.1
x
|
13.4
x
|
16.3
x
|
19.9
x
|
9.62
x
|
13.3
x
|
14.4
x
|
13.6
x
|
Yield
|
1.37%
|
1.94%
|
1.81%
|
1.53%
|
2.26%
|
2.06%
|
2.13%
|
2.22%
|
Capitalization / Revenue
|
5.86
x
|
4.85
x
|
6.04
x
|
6.77
x
|
4.12
x
|
4.65
x
|
4.95
x
|
4.8
x
|
EV / Revenue
|
4.96
x
|
4.24
x
|
5.14
x
|
6.04
x
|
3.42
x
|
3.59
x
|
3.6
x
|
3.29
x
|
EV / EBITDA
|
11.4
x
|
9.84
x
|
11.5
x
|
16
x
|
8.78
x
|
9.05
x
|
9.51
x
|
8.74
x
|
EV / FCF
|
13
x
|
11.6
x
|
14.7
x
|
345
x
|
11.3
x
|
10.3
x
|
9.78
x
|
9.24
x
|
FCF Yield
|
7.71%
|
8.62%
|
6.8%
|
0.29%
|
8.88%
|
9.73%
|
10.2%
|
10.8%
|
Price to Book
|
3.2
x
|
2.11
x
|
2.12
x
|
2.33
x
|
1.6
x
|
1.78
x
|
1.65
x
|
1.52
x
|
Nbr of stocks (in thousands)
|
310,970
|
303,785
|
301,465
|
301,483
|
294,307
|
283,491
|
-
|
-
|
Reference price
2 |
6,852
|
5,317
|
5,952
|
7,530
|
5,977
|
7,306
|
7,306
|
7,306
|
Announcement Date
|
5/9/19
|
5/11/20
|
5/10/21
|
5/11/22
|
5/10/23
|
-
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
363,721
|
333,371
|
297,177
|
335,100
|
426,684
|
445,161
|
418,741
|
431,243
|
EBITDA
1 |
157,700
|
143,682
|
132,238
|
126,700
|
166,168
|
176,548
|
158,310
|
162,501
|
EBIT
1 |
138,500
|
130,628
|
117,438
|
110,300
|
149,003
|
157,948
|
140,956
|
147,986
|
Operating Margin
|
38.08%
|
39.18%
|
39.52%
|
32.92%
|
34.92%
|
35.48%
|
33.66%
|
34.32%
|
Earnings before Tax (EBT)
1 |
170,343
|
158,516
|
143,018
|
126,300
|
220,332
|
199,595
|
184,725
|
193,824
|
Net income
1 |
132,800
|
122,193
|
111,858
|
114,200
|
184,965
|
159,588
|
145,771
|
152,846
|
Net margin
|
36.51%
|
36.65%
|
37.64%
|
34.08%
|
43.35%
|
35.85%
|
34.81%
|
35.44%
|
EPS
2 |
424.3
|
395.7
|
365.0
|
378.8
|
621.3
|
550.7
|
508.3
|
538.5
|
Free Cash Flow
1 |
139,136
|
121,986
|
103,778
|
5,864
|
129,575
|
155,481
|
154,000
|
153,667
|
FCF margin
|
38.25%
|
36.59%
|
34.92%
|
1.75%
|
30.37%
|
34.93%
|
36.78%
|
35.63%
|
FCF Conversion (EBITDA)
|
88.23%
|
84.9%
|
78.48%
|
4.63%
|
77.98%
|
88.07%
|
97.28%
|
94.56%
|
FCF Conversion (Net income)
|
104.77%
|
99.83%
|
92.78%
|
5.13%
|
70.05%
|
97.43%
|
105.65%
|
100.54%
|
Dividend per Share
2 |
94.00
|
103.0
|
108.0
|
115.0
|
135.0
|
150.8
|
155.5
|
162.4
|
Announcement Date
|
5/9/19
|
5/11/20
|
5/10/21
|
5/11/22
|
5/10/23
|
-
|
-
|
-
|
Fiscal Period: März |
2020 S1
|
2020 S2
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
160,877
|
174,081
|
148,452
|
76,120
|
145,085
|
74,541
|
115,500
|
71,800
|
78,900
|
150,779
|
187,568
|
88,337
|
109,312
|
121,230
|
230,542
|
106,279
|
109,812
|
94,526
|
-
|
187,740
|
-
|
-
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
45,198
|
14,561
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
58,161
|
67,070
|
55,308
|
23,870
|
42,664
|
17,758
|
49,900
|
12,400
|
15,800
|
28,224
|
118,249
|
2,530
|
46,585
|
51,521
|
98,106
|
40,631
|
18,995
|
34,060
|
-
|
62,786
|
-
|
-
|
Operating Margin
|
36.15%
|
38.53%
|
37.26%
|
31.36%
|
29.41%
|
23.82%
|
43.2%
|
17.27%
|
20.03%
|
18.72%
|
63.04%
|
2.86%
|
42.62%
|
42.5%
|
42.55%
|
38.23%
|
17.3%
|
36.03%
|
-
|
33.44%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
67,386
|
91,178
|
67,189
|
27,891
|
50,832
|
23,952
|
51,500
|
40,300
|
27,700
|
67,978
|
130,808
|
21,546
|
55,704
|
59,899
|
115,603
|
48,884
|
35,800
|
42,960
|
-
|
80,586
|
-
|
-
|
Net income
1 |
51,616
|
69,679
|
49,381
|
20,893
|
53,131
|
17,869
|
43,200
|
34,700
|
22,500
|
57,264
|
100,465
|
27,236
|
42,562
|
48,031
|
90,593
|
36,629
|
35,558
|
34,060
|
-
|
62,786
|
-
|
-
|
Net margin
|
32.08%
|
40.03%
|
33.26%
|
27.45%
|
36.62%
|
23.97%
|
37.4%
|
48.33%
|
28.52%
|
37.98%
|
53.56%
|
30.83%
|
38.94%
|
39.62%
|
39.3%
|
34.46%
|
32.38%
|
36.03%
|
-
|
33.44%
|
-
|
-
|
EPS
2 |
165.8
|
-
|
160.8
|
69.30
|
176.2
|
59.27
|
143.2
|
115.2
|
75.04
|
190.2
|
337.6
|
93.50
|
144.6
|
164.0
|
308.6
|
127.2
|
131.5
|
122.6
|
-
|
226.0
|
-
|
-
|
Dividend per Share
2 |
50.00
|
-
|
53.00
|
-
|
55.00
|
-
|
-
|
-
|
-
|
60.00
|
-
|
-
|
-
|
75.00
|
75.00
|
-
|
75.00
|
-
|
80.00
|
-
|
-
|
80.00
|
Announcement Date
|
10/30/19
|
5/11/20
|
10/30/20
|
11/1/21
|
11/1/21
|
1/31/22
|
5/11/22
|
8/1/22
|
10/31/22
|
10/31/22
|
1/30/23
|
5/10/23
|
7/31/23
|
10/31/23
|
10/31/23
|
1/31/24
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
325,893
|
200,709
|
268,186
|
247,746
|
299,813
|
473,352
|
565,792
|
650,681
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
139,136
|
121,986
|
103,778
|
5,864
|
129,575
|
155,481
|
154,000
|
153,667
|
ROE (net income / shareholders' equity)
|
20.9%
|
15.5%
|
13.9%
|
12.5%
|
17.8%
|
14%
|
11.6%
|
11.5%
|
ROA (Net income/ Total Assets)
|
22.2%
|
19.6%
|
11.9%
|
10.6%
|
17.9%
|
12.1%
|
9.74%
|
9.64%
|
Assets
1 |
598,424
|
625,008
|
936,340
|
1,074,793
|
1,033,572
|
1,324,384
|
1,496,622
|
1,585,536
|
Book Value Per Share
2 |
2,144
|
2,517
|
2,807
|
3,236
|
3,738
|
4,115
|
4,436
|
4,792
|
Cash Flow per Share
2 |
477.0
|
441.0
|
413.0
|
433.0
|
679.0
|
620.0
|
587.0
|
584.0
|
Capex
1 |
6,548
|
9,954
|
27,400
|
26,185
|
11,858
|
29,814
|
27,300
|
27,163
|
Capex / Sales
|
1.8%
|
2.99%
|
9.22%
|
7.81%
|
2.78%
|
6.7%
|
6.52%
|
6.3%
|
Announcement Date
|
5/9/19
|
5/11/20
|
5/10/21
|
5/11/22
|
5/10/23
|
-
|
-
|
-
|
Last Close Price
7,306
JPY Average target price
7,721
JPY Spread / Average Target +5.68% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.47% | 13.16B | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|